Vemurafenib (VEM) in patients (pts) with BRAF-mutant melanoma and brain metastases (mets) Meeting Abstract


Authors: Harding, J. J.; Catalanotti, F.; Yaqubie, A.; McDermott, G. C.; Kersellius, R.; Merghoub, T.; Carvajal, R. D.; D'Angelo, S. P.; Dickson, M. A.; Schwartz, G. K.; Wolchok, J. D.; Berger, M. F.; Solit, D. B.; Chapman, P. B.
Abstract Title: Vemurafenib (VEM) in patients (pts) with BRAF-mutant melanoma and brain metastases (mets)
Meeting Title: 49th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 15 Suppl.
Meeting Dates: 2013 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-05-20
Language: English
ACCESSION: WOS:000335419602761
PROVIDER: wos
Notes: Meeting Abstract: 9060 -- Source: Wos
MSK Authors
  1. Gary Schwartz
    358 Schwartz
  2. Jedd D Wolchok
    656 Wolchok
  3. Taha Merghoub
    201 Merghoub
  4. David Solit
    431 Solit
  5. Richard D Carvajal
    133 Carvajal
  6. James Joseph Harding
    66 Harding
  7. Paul Chapman
    246 Chapman
  8. Mark Andrew Dickson
    77 Dickson
  9. Michael Forman Berger
    380 Berger
  10. Manuela F Berger
    5 Berger